515 related articles for article (PubMed ID: 19336547)
1. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
[TBL] [Abstract][Full Text] [Related]
2. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.
Chien YC; Chen JY; Liu MY; Yang HI; Hsu MM; Chen CJ; Yang CS
N Engl J Med; 2001 Dec; 345(26):1877-82. PubMed ID: 11756578
[TBL] [Abstract][Full Text] [Related]
3. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency.
Chen CJ; Liang KY; Chang YS; Wang YF; Hsieh T; Hsu MM; Chen JY; Liu MY
Anticancer Res; 1990; 10(2B):547-53. PubMed ID: 2161639
[TBL] [Abstract][Full Text] [Related]
4. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
12. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.
Hildesheim A; West S; DeVeyra E; De Guzman MF; Jurado A; Jones C; Imai J; Hinuma Y
Cancer Res; 1992 Jun; 52(11):3048-51. PubMed ID: 1317256
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
14. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
Lo S; Ho WK; Wei WI
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
18. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
20. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation.
Xu FH; Xiong D; Xu YF; Cao SM; Xue WQ; Qin HD; Liu WS; Cao JY; Zhang Y; Feng QS; Chen LZ; Li MZ; Liu ZW; Liu Q; Hong MH; Shugart YY; Zeng YX; Zeng MS; Jia WH
J Natl Cancer Inst; 2012 Sep; 104(18):1396-410. PubMed ID: 22972969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
